Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ASCO Annual Meeting 2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

2024 ASCO Annual Meeting

Keep up to date with all the top stories and latest evidence with our hub page, including official congress videos and expert takeaways.
ADVANCED SEARCH
Log in
Top
Internal and Emergency Medicine
Literature
1.
Fox DM (1988) The politics of physicians’ responsibility in epidemics: a note on history. Hastings Cent Rep 18:5–10CrossRef
2.
Malm H, May T, Francis LP, Omer SB, Salmon DA, Hood R (2008) Ethics, pandemics, and the duty to treat. Am J Bioeth 8:4–19CrossRef
3.
4.
Lippi D, Gensini GF, Conti AA (2003) Charter on medical professionalism: putting the charter into practice. Ann Intern Med 138:852–853CrossRef
5.
Lippi D. (2015) La Medicina e gli ospedali fiorentini durante la grande guerra. In: Perfetti F, editor. Atti del convegno Niente fu più come prima. La grande guerra e l'Italia cento anni dopo: 13-14 marzo 2015; Firenze. Firenze: Polistampa. 219-230
6.
Metadata
Title
Role of doctors in epidemics: historical perspectives and implications for COVID-19
Authors
Donatella Lippi
Raffaella Bianucci
Simon Donell
Publication date
01-08-2020
Publisher
Springer International Publishing
Keywords
Plague
COVID-19
Published in
Internal and Emergency Medicine / Issue 5/2020
Print ISSN: 1828-0447
Electronic ISSN: 1970-9366
DOI
https://doi.org/10.1007/s11739-020-02351-x

Other articles of this Issue 5/2020

Internal and Emergency Medicine 5/2020 Go to the issue

CE - LETTER TO THE EDITOR

Bilateral lower limb weakness: a cerebrovascular consequence of covid-19 or a complication associated with it?

IM-Point of view

The SARS-CoV-2 receptor, ACE-2, is expressed on many different cell types: implications for ACE-inhibitor- and angiotensin II receptor blocker-based cardiovascular therapies

IM-Point of view

SARS-CoV-2 and myocardial injury: a role for Nox2?

IM-Point of view

Potential role of incretins in diabetes and COVID-19 infection: a hypothesis worth exploring

Editor's Page

“COVID-19: diagnosis, management and prognosis”: a new topical collection of Internal and Emergency Medicine

CE-Research Letter to the Editor

Out-of-hospital cardiac arrest prognosis during the COVID-19 pandemic
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits